X0304 4/A 2011-07-06 2012-01-30 0 0001053369 ELITE PHARMACEUTICALS INC /DE/ ELTP 0001442002 EPIC PHARMA LLC 227-15 NORTH CONDUIT AVE LAURELTON NY 11413-3134 0 0 1 0 Common Stock 2011-07-06 4 C 0 2976190 0 A 2976190 I see footnote Series E Convertible Preferred Stock 0.0252 2011-07-06 4 C 0 75 1000 D 2011-07-06 Common Stock 2976190 2978.5 I see footnote This amended Form 4 is being filed to correct the transaction date that was incorrectly reported. The correct transaction date is July 6, 2011, not June 6, 2011 as originally reported. The reporting person, Epic Pharma, LLC ("EP"), is an equity owner of Epic Investments, LLC ("EI"), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer. EP and EI are both owned, wholly or in part, and are operated by Ram Potti, Ashok G. Nigalaye and Jeenarine Narine, each of whom is a director of the issuer. The interest of EP in the securities of the issuer owned by EI is limited, and EP disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI N/A Ram Potti 2012-02-08